Clinical Trial Update: A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED) [Phase 2]

View source ↗

Summary

This is a completed Phase 2 pharmacokinetics/pharmacodynamics study of SCH 900518 in previously untreated subjects with genotype 1 chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SCH 900518

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED